What is the maximum Clevatess dose?

Understanding Maximum Clevatess Dosage

What is the maximum Clevatess dose? The maximum recommended dose of Clevatess (clevidipine butyrate) is 32 mg/hour (21 drops per minute) for most patients requiring blood pressure management in acute care settings.

Standard Dosing Guidelines

Clevatess is an intravenous calcium channel blocker used primarily for perioperative hypertension management. The medication follows a carefully structured dosing protocol:

- Initial dose: 1-2 mg/hour (0.5-1 drop per minute)

- Titration: Double the dose every 90 seconds initially, then increase by less frequent intervals

- Maximum dose: 32 mg/hour (21 drops per minute)

- Maximum duration: Generally limited to 72 hours of continuous infusion

Important Dosing Considerations

Patient-Specific Factors

Certain patients may require dose modifications below the maximum threshold. Elderly patients, those with severe hepatic impairment, or individuals with compromised cardiovascular function may need reduced maximum doses based on clinical response and tolerability.

Monitoring Requirements

When approaching higher Clevatess doses, continuous blood pressure monitoring becomes critical. Healthcare providers should assess patient response every few minutes and adjust accordingly to avoid excessive hypotension.

Safety Parameters

Exceeding the maximum Clevatess dose of 32 mg/hour significantly increases the risk of severe hypotension, reflex tachycardia, and potential cardiovascular compromise. The lipid load from the formulation also becomes a consideration at maximum dosing, particularly in patients with existing lipid disorders.

Clinical Context

Most patients achieve adequate blood pressure control well below the maximum dose. Healthcare providers typically find effective control between 4-16 mg/hour, reserving higher doses for refractory hypertensive episodes.

Understanding proper Clevatess dosing ensures optimal patient outcomes while minimizing adverse effects. Always consult current prescribing information and healthcare providers for patient-specific dosing recommendations.